{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T21:37:43Z","timestamp":1782337063213,"version":"3.54.5"},"reference-count":90,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.revmed.2018.02.001","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T19:23:41Z","timestamp":1519673021000},"page":"711-720","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Scl\u00e9rites et maladies syst\u00e9miques\u00a0: que doit savoir l\u2019interniste\u00a0?"],"prefix":"10.1016","volume":"39","author":[{"given":"P.","family":"Bielefeld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Saadoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"H\u00e9ron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Devilliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Deschasse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8927-9180","authenticated-orcid":false,"given":"S.","family":"Trad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"S\u00e8ne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Kaplanski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"S\u00e8ve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.02.001_bib0005","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrrheum.2013.185","article-title":"Ocular inflammatory diseases associated with rheumatoid arthritis","volume":"10","author":"Artifoni","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0010","first-page":"1","article-title":"Ocular autoimmune systemic inflammatory infectious study (OASIS) \u2013\u00a0report 1: epidemiology and classification","volume":"5","author":"Chen","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0015","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0002-9394(00)00710-8","article-title":"Episcleritis and scleritis: clinical features and treatment results","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0020","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/bjo.60.3.163","article-title":"Scleritis and episcleritis","volume":"60","author":"Watson","year":"1976","journal-title":"Brit J Ophthal"},{"key":"10.1016\/j.revmed.2018.02.001_bib0025","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","article-title":"Incidence and prevalence of episcleritis and scleritis in northern California","volume":"32","author":"Honik","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.revmed.2018.02.001_bib0030","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ajo.2007.09.024","article-title":"Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis","volume":"145","author":"Lin","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0035","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1016\/S0161-6420(99)90543-2","article-title":"Posterior scleritis: clinical features, systemic associations and outcome in a large series of patients","volume":"106","author":"McCluskey","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0040","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.revmed.2013.09.013","article-title":"Scl\u00e9rites, aspects cliniques, \u00e9tiologiques et th\u00e9rapeutiques\u00a0: \u00e0 propos d\u2019une s\u00e9rie de 32\u00a0observations","volume":"35","author":"L\u00e9al","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2018.02.001_bib0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.ajo.2009.06.025","article-title":"Chronic herpes simplex scleritis: characterization of 9\u00a0cases of an underrecognized clinical entity","volume":"148","author":"Bhat","year":"2009","journal-title":"Am J Ophthalmol."},{"key":"10.1016\/j.revmed.2018.02.001_bib0050","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.survophthal.2012.11.002","article-title":"The spectrum of postoperative scleral necrosis","volume":"58","author":"Doshi","year":"2013","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0055","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1136\/bjo.76.1.17","article-title":"Surgically induced necrotising sclerokeratitis (SINS)-precipitating factors and response to treatment","volume":"76","author":"O\u2019Donoghue","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0060","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.revmed.2014.02.004","article-title":"Scleritis and episcleritis: diagnosis and treatment","volume":"35","author":"H\u00e9ron","year":"2014","journal-title":"Rev Med Interne"},{"key":"10.1016\/j.revmed.2018.02.001_bib0065","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00198-014-2872-5","article-title":"Incidence of ocular side effects with intravenous zoledronate: secondary analysis of a randomized controlled trial","volume":"26","author":"Patel","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.revmed.2018.02.001_bib0070","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","article-title":"Scleritis","volume":"50","author":"Okhravi","year":"2005","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0075","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ophtha.2003.06.006","article-title":"Evaluation of patients with scleritis for systemic disease","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ophtha.2011.07.013","article-title":"Clinical characteristics of a large cohort of patients with scleritis and episcleritis","volume":"119","author":"Sainz-de-la-Maza","year":"2012","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0085","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1093\/rheumatology\/kex057","article-title":"Ocular involvement in patients with spondyloarthritis","volume":"56","author":"Bacchiega","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.revmed.2018.02.001_bib0090","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.survophthal.2016.06.002","article-title":"Treatment and management of scleral disorders","volume":"61","author":"Diaz","year":"2016","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.jfo.2010.07.001","article-title":"Scl\u00e9rites, quand \u00e9voquer une pathologie syst\u00e9mique\u00a0?","volume":"33","author":"Gabison","year":"2010","journal-title":"J Fr Ophtalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0100","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00417-014-2772-6","article-title":"Acute anterior uveitis and undiagnosed spondyloarthritis: usefulness of Berlin criteria","volume":"253","author":"Wach","year":"2015","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0105","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.ajo.2009.07.021","article-title":"Scleritis and systemic disease association in a community-based referral practice","volume":"148","author":"Raiji","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0110","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","article-title":"Visual outcome, treatment results and prognostic factors in patients with scleritis","volume":"120","author":"Wieringa","year":"2013","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ncprheum0454","article-title":"Therapy insight: scleritis and its relationship to systemic autoimmune disease","volume":"3","author":"Smith","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0120","series-title":"\u0152il et maladies syst\u00e9miques","first-page":"185","article-title":"Polyarthrite rhumato\u00efde","author":"Artifoni","year":"2014"},{"key":"10.1016\/j.revmed.2018.02.001_bib0125","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/art.1780381114","article-title":"Peripheral neuropathy with necrotizing vasculitis in rheumatoid arthritis. A clinicopathologic and prognostic study of thirty-two patients","volume":"38","author":"Pu\u00e9chal","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.001_bib0130","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3341\/kjo.2011.25.4.275","article-title":"A case of necrotizing keratoscleritis in primary Sjogren's syndrome","volume":"25","author":"Choi","year":"2011","journal-title":"Korean J Ophthalmol"},{"issue":"9","key":"10.1016\/j.revmed.2018.02.001_bib0135","first-page":"393","article-title":"Ocular manifestations of rheumatoid arthritis and their correlation with anti-cyclic citrullinated peptide antibodies","volume":"25","author":"Vignesh","year":"2015","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0140","first-page":"184","article-title":"Inflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort study","volume":"15","author":"Etminan","year":"2012","journal-title":"CMAJ"},{"key":"10.1016\/j.revmed.2018.02.001_bib0145","doi-asserted-by":"crossref","first-page":"e000239","DOI":"10.1136\/rmdopen-2015-000239","article-title":"Paradoxical reactions under TNF-\u03b1 blocking agents and other biological agents given for chronic immune-mediated diseases: an analytical and comprehensive overview","volume":"2","author":"Toussirot","year":"2016","journal-title":"RMD Open"},{"key":"10.1016\/j.revmed.2018.02.001_bib0150","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3899\/jrheum.110865","article-title":"Scleritis: a paradoxical effect of etanercept? Etanercept-associated inflammatory eye disease","volume":"39","author":"Gaujoux-Viala","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0155","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.semarthrit.2012.08.003","article-title":"Ophthalmologic manifestations of systemic necrotizing vasculitides at diagnosis: a retrospective study of 1286\u00a0patients and review of the literature","volume":"42","author":"Rothschild","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.revmed.2018.02.001_bib0160","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0161-6420(83)34574-7","article-title":"Ocular complications of Wegener's granulomatosis","volume":"90","author":"Bullen","year":"1983","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0165","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s12177-009-9044-4","article-title":"Ocular disease in patients with ANCA \u2013\u00a0positive vasculitis","volume":"3","author":"Watkins","year":"2009","journal-title":"J Ocul Biol Dis Infor"},{"key":"10.1016\/j.revmed.2018.02.001_bib0170","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1136\/bjophthalmol-2015-307460","article-title":"Scleritis in patients with granulomatosis with polyangiitis (Wegener)","volume":"100","author":"Cocho","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0175","series-title":"\u0152il et maladies syst\u00e9miques","first-page":"244","article-title":"Vascularites n\u00e9crosantes","author":"Rothschild","year":"2014"},{"key":"10.1016\/j.revmed.2018.02.001_bib0180","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27\u00a0in the French population: results of the GAZEL cohort","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.001_bib0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.3899\/jrheum.150630","article-title":"Uveitis in spondyloarthritis: an overview","volume":"93","author":"Cantini","year":"2015","journal-title":"J Rheumatol Suppl"},{"key":"10.1016\/j.revmed.2018.02.001_bib0190","doi-asserted-by":"crossref","first-page":"e4233","DOI":"10.1097\/MD.0000000000004233","article-title":"Risk factors of uveitis in ankylosing spondylitis: an observational study","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2018.02.001_bib0195","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1136\/annrheumdis-2013-203582","article-title":"Prevalence of extra-articular manifestations in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"74","author":"Stolwijk","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.revmed.2018.02.001_bib0200","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/ICU.0000000000000209","article-title":"Ocular involvement in systemic lupus erythematosus","volume":"26","author":"Preble","year":"2015","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0205","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3109\/09273948.2015.1005240","article-title":"Posterior scleritis: analysis of epidemiology, clinical factors and risk of recurrence in a cohort of 114\u00a0patients","volume":"24","author":"Lavric","year":"2016","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0210","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0161-6420(95)30970-0","article-title":"Scleritis associated with systemic vasculitic diseases","volume":"102","author":"Sainz-de-la-Maza","year":"1995","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0215","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00005792-197605000-00001","article-title":"Relapsing polychondritis: prospective study of 23\u00a0patients and a review of the literature","volume":"55","author":"McAdam","year":"1976","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.revmed.2018.02.001_bib0220","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/08820538.2011.588653","article-title":"Relapsing polychondritis: systemic and ocular manifestations, differential diagnosis, management and prognosis","volume":"26","author":"Yoo","year":"2011","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0225","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0161-6420(86)33695-9","article-title":"Ocular and systemic findings in relapsing polychondritis","volume":"93","author":"Isaak","year":"1986","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0230","first-page":"96","article-title":"Relapsing polychondritis: clinical and immunogenetic analysis of 62\u00a0patients","volume":"24","author":"Zeuner","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0235","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/bjophthalmol-2015-306902","article-title":"Scleritis associated with relapsing polychondritis","volume":"100","author":"Sainz-de-la-Maza","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0240","doi-asserted-by":"crossref","first-page":"201","DOI":"10.11622\/smedj.2016047","article-title":"Relapsing polychondritis in Singapore: a case series and review of literature","volume":"58","author":"Chuah","year":"2017","journal-title":"Singapore Med J"},{"key":"10.1016\/j.revmed.2018.02.001_bib0245","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09273941003624914","article-title":"Infliximab in a patient with refractory necrotizing scleritis associated with relapsing polychondritis","volume":"18","author":"Jabbarvand","year":"2010","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0250","doi-asserted-by":"crossref","first-page":"e795","DOI":"10.1111\/aos.13376","article-title":"IgG4-related disease as an emerging cause of scleritis","volume":"95","author":"Karim","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0255","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/bjophthalmol-2014-305545","article-title":"An analysis of IgG4-related disease (IgG4-RD) among idiopathic orbital inflammations and benign lymphoid hyperplasias using two consensus-based diagnostic criteria for IgG4-RD","volume":"99","author":"Andrew","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10384-014-0352-2","article-title":"Japanese study group for IgG4-related ophthalmic disease. diagnostic criteria for IgG-4\u00a0related ophthalmic disease","volume":"59","author":"Goto","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0265","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/MD.0000000000006205","article-title":"Ophthalmic manifestations in IgG4-related disease: clinical presentation and response to treatment in a French case series","volume":"96","author":"Ebbo","year":"2017","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2018.02.001_bib0270","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/09273948.2012.709574","article-title":"IgG4-positive sclerosing orbital inflammation involving the conjunctiva: a case report","volume":"20","author":"Paulus","year":"2012","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0275","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/ICU.0000000000000427","article-title":"IgG4-related disease in the eye and ocular adnexa","volume":"28","author":"Derzko-Dzulynsky","year":"2017","journal-title":"Curr Opin Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0280","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbspin.2013.07.011","article-title":"Successful use of rituximab in a young patient with immunoglobulin G4-related disease and refractory scleritis","volume":"81","author":"Caso","year":"2014","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.revmed.2018.02.001_bib0285","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/14397595.2013.852842","article-title":"IgG4-related disease involving the sclera","volume":"24","author":"Ohno","year":"2014","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0290","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12348-015-0047-y","article-title":"IgG4-associated orbital and ocular inflammation","volume":"5","author":"Lee","year":"2015","journal-title":"J Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.revmed.2018.02.001_bib0295","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3109\/09273948.2014.985384","article-title":"IgG4-related disease masquerading as recurrent scleritis and chronic conjunctivitis","volume":"23","author":"Philippakis","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0300","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12348-017-0125-4","article-title":"IgG4\u00a0related disease presenting as panuveitis without scleral involvement","volume":"7","author":"Najem","year":"2017","journal-title":"J Ophthal Inflamm Infect"},{"key":"10.1016\/j.revmed.2018.02.001_bib0305","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-219568","article-title":"Case report: IgG4-related disease presenting as posterior scleritis and vitritis, progressing to multifocal orbital involvement","author":"Reynolds","year":"2017","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.revmed.2018.02.001_bib0310","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000447405","article-title":"Immunoglobulin G4-related ophthalmic disease involving the sclera misdiagnosed as intraocular tumor: report of one case","volume":"2","author":"Goto","year":"2016","journal-title":"Ocular Oncol Pathol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0315","doi-asserted-by":"crossref","first-page":"601","DOI":"10.4103\/0301-4738.191510","article-title":"IgG4-related intraocular inflammation masquerading as ciliary body melanoma in a young girl","volume":"64","author":"Das","year":"2016","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0320","article-title":"Case report: IgG4-related disease presenting as isolated scleritis","author":"Berkkowitz","year":"2017","journal-title":"Case Rep Ophthal Med"},{"issue":"Suppl. 1","key":"10.1016\/j.revmed.2018.02.001_bib0325","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.3109\/09273948.2015.1133840","article-title":"Frequency of uveitis in the central Tokyo area (2010\u20132012)","volume":"25","author":"Nakahara","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0330","first-page":"1","article-title":"Bilateral posterior scleritis associated with giant cell arteritis: a case report","volume":"15","author":"Erdogan","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0335","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1080\/09273940600826612","article-title":"Recurrent nodular scleritis preceding an adult TINU syndrome","volume":"14","author":"Daniel","year":"2006","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0340","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s10384-010-0889-7","article-title":"Infliximab for progressive peripheral ulcerative keratitis in a patient with juvenile rheumatoid arthritis","volume":"55","author":"Oh","year":"2011","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0345","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s10384-009-0729-9","article-title":"case of atypical Cogan's syndrome with posterior scleritis and uveitis","volume":"53","author":"Yaginuma","year":"2009","journal-title":"Jpn J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0350","first-page":"1","article-title":"Clinical characteristics of ocular sarcoidosis: a population-based study 1976\u20132013","volume":"12","author":"Ungprasert","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0355","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3109\/09273948.2013.840385","article-title":"Clinical features and presentation of posterior scleritis: a report of 31\u00a0cases","volume":"22","author":"Gonzalez-Gonzalez","year":"2014","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0360","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1089\/jop.2016.0127","article-title":"Ocular pharmacology for scleritis: review of treatment and a practical perspective","volume":"33","author":"Stem","year":"2017","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.revmed.2018.02.001_bib0365","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1869-5760-3-7","article-title":"Subconjunctival dexamethasone implant for non-necrotizing scleritis","volume":"3","author":"Nascimento","year":"2013","journal-title":"Ophthalmic Inflamm Infect"},{"key":"10.1016\/j.revmed.2018.02.001_bib0370","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1586\/1744666X.2016.1171713","article-title":"Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects","volume":"12","author":"Oray","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0375","doi-asserted-by":"crossref","first-page":"184","DOI":"10.3109\/09273948.2013.874446","article-title":"Cotrimoxazole as a treatment for recurrent idiopathic anterior scleritis: a single-center experience in 20\u00a0patients","volume":"23","author":"Bielefeld","year":"2015","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0380","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.ajo.2014.12.009","article-title":"Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I\/II clinical trial","volume":"159","author":"Bhatt","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0385","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.ajo.2009.05.008","article-title":"Azathioprine for ocular inflammatory diseases","volume":"148","author":"Pasadhika","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0390","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","volume":"116","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0395","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.ajo.2009.09.026","article-title":"Mycophenolate mofetil for ocular inflammation","volume":"149","author":"Daniel","year":"2010","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0400","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.ophtha.2009.06.060","article-title":"Cyclophosphamide for ocular inflammatory diseases","volume":"117","author":"Pujari","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0405","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ophtha.2009.08.010","article-title":"Cyclosporine for ocular inflammatory diseases","volume":"117","author":"Kacmaz","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/j.1442-9071.2005.00955.x","article-title":"Successful treatment of surgically induced necrotizing scleritis with tacrolimus","volume":"33","author":"Young","year":"2005","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0415","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1136\/bjophthalmol-2015-307462","article-title":"Efficacy and safety of immunosuppressive agents in the treatment of necrotising scleritis: a retrospective, multicentre study in Korea","volume":"100","author":"Jeon","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0420","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s10792-015-0124-0","article-title":"Biologic therapy for refractory scleritis: a new treatment perspective","volume":"35","author":"de Fidelix","year":"2015","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0425","doi-asserted-by":"crossref","first-page":"e400","DOI":"10.1111\/aos.13015","article-title":"Outcome of tocilizumab treatment in refractory ocular inflammatory diseases","volume":"94","author":"Silpa-Archa","year":"2016","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0430","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.ophtha.2015.01.016","article-title":"Long-term outcomes of rituximab therapy in ocular granulomatosis with polyangiitis: impact on localized and nonlocalized Disease","volume":"122","author":"Joshi","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.revmed.2018.02.001_bib0435","first-page":"1","article-title":"Rituximab induction and maintenance treatment in patients with scleritis and granulomatosis with polyangiitis (Wegener's)","volume":"19","author":"You","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0440","first-page":"1","article-title":"Anakinra in the treatment of patients with refractory scleritis: a pilot study","volume":"24","author":"Bottin","year":"2017","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.revmed.2018.02.001_bib0445","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ajo.2016.09.017","article-title":"Gevokizumab in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I\/II clinical trial","volume":"172","author":"Knickelbein","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.revmed.2018.02.001_bib0450","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14656566.2013.772982","article-title":"Pharmacotherapy of scleritis: current paradigms and future directions","volume":"14","author":"Beardsley","year":"2013","journal-title":"Expert Opin Pharmacother"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300377?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318300377?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:40:07Z","timestamp":1759336807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318300377"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":90,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0248866318300377"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.02.001","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scl\u00e9rites et maladies syst\u00e9miques\u00a0: que doit savoir l\u2019interniste\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}